Kye Pharmaceuticals ranks No. 105 with 264% three-year growth

  • Kye Pharmaceuticals ranked No. 105 on Canada’s Top Growing Companies list.
  • Kye Pharmaceuticals recorded 264% three-year revenue growth for the 2026 ranking.
  • Kye Pharmaceuticals received its second consecutive appearance on the ranking.

Kye Pharmaceuticals ranked No. 105 on Report on Business magazine’s 2026 list of Canada’s Top Growing Companies after recording 264% revenue growth over three years. The Mississauga-based company, which focuses on identifying, licensing and commercializing prescription medicines for patients in Canada, said it was recognized for the second consecutive year. A total of 376 companies qualified for the voluntary editorial ranking, which was launched in 2019 and evaluates Canadian businesses on three-year revenue growth. The 2026 winners were published in the October issue of Report on Business magazine and online.

The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.